Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-02-03 @ 7:28 AM
Study NCT ID:
NCT03170895
Status:
COMPLETED
Last Update Posted:
2020-03-30
First Post:
2017-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
Sponsor:
The University of Hong Kong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AML008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None